Neoadjuvant AXITINIB and AVELUMAB for Patients With Localized Clear-cell RCC
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Axitinib
Related studies linked through entity extraction aliases.
Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trial on the Combination of Avelumab and Axitinib for the Treatment of Patients With Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Nivolumab and Axitinib in Patients With Advanced Renal Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
The Drug Rediscovery Protocol (DRUP Trial)
- Status
- RECRUITING
- Phase
- PHASE2
Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Axitinib in Patients With Recurred or Metastatic Adenoid Cystic Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Axitinib in R/M Salivary Gland Cancers of the Upper Aerodigestive Tract - SGC-AX14
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Axitinib Versus Sunitinib Monotherapy in Participants With Renal Cell Carcinoma (MK-3475-426/KEYNOTE-426)
- Status
- COMPLETED
- Phase
- PHASE3
The Safety and Maximum Tolerated Dose of Axitinib in Combination With Radiotherapy for HCC
- Status
- COMPLETED
- Phase
- PHASE1
Axitinib and Bosutinib in Treating Patients With Chronic, Accelerated, or Blastic Phase Chronic Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Expansion Trial for Axitinib In Head And Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Axitinib in Metastatic Renal Cell Carcinoma Patients With Favorable Prognostic Factors
- Status
- COMPLETED
- Phase
- PHASE2
Trial of X4P-001 in Participants With Advanced Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy
- Status
- UNKNOWN
- Phase
- PHASE2
Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas
- Status
- COMPLETED
- Phase
- PHASE2
Study of Axitinib for Downstaging Large Renal Tumors Not Primarily Suitable for Partial Nephrectomy (AXIPAN)
- Status
- COMPLETED
- Phase
- PHASE2
Axitinib Given on an Individualized Schedule for Metastatic Renal Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE2